Set point theory

Last updated

Set point theory, as it pertains to human body weight, states that there is a biological control method in humans that actively regulates weight towards a predetermined set weight for each individual. [1] This may occur through regulation of energy intake (e.g.via increased or decreased appetite) or energy expenditure (e.g. via reduced metabolism or feelings of lethargy). [1] [2] Set point theory explains why it is difficult for dieters to maintain weight loss over time, as calorie restriction may become less effective or more difficult to maintain as regulatory mechanisms in the body actively push the body back towards the set point weight. [3]

Contents

Set point theory differentiates between active compensation and passive compensation. In active compensation, a regulatory mechanism in the body affects energy expenditure or intake. In passive compensation, a decrease in body fat levels leads to a decrease in energy compensation even without a regulatory mechanism as there is less weight to be carried. Set point theory posits active compensation in addition to passive compensation. [4]

Set point theory can be construed as implying weight regulation in a wide or tight range around the set point, in a symmetric or in an asymmetric manner (i.e. treating weight gain and loss either the same or differently), and may apply to regulation of body fat levels specifically (in a multi-compartment model) or to overall body weight.

Set point theory applies to both downward and upward adjustment of weight. [2] [5] This return to the pre-change weight occurs faster than would be expected if individuals simply returned to their normal caloric intake and energy expenditure even after accounting for lower energy needs after weight loss, indicating an active response by the body encouraging weight gain. [4] While the set point applies to both deviations driven by weight loss and weight gain, the set point response driving a person to regain weight to regain the set point is stronger than the response to lose weight after gaining weight above the set point, implying that it may be easier to gain than to lose weight.

Evidence

In humans, when calories are restricted because of war, famine, or diet, lost weight is typically regained quickly, including for obese patients. [2] In the Minnesota Starvation Experiment, after human subjects were fed a near-starvation diet for a period, losing 66% of their initial fat mass, and later allowed to eat freely, they reattained and even surpassed their original fat levels, reaching 145% of the pre-starvation fat levels. [6] [7]

Evidence for an organism-level set point has been found experimentally in "normal" rats and in rats with dorsomedial hypothalamic lesions. [8]

Mechanism

As there has not been one unique mechanism identified to be behind weight regulation, it is likely that there are multiple factors reaching a shared equilibrium that result in a stable bodyweight. [1] Leptin is known to play a key role in appetite and thus weight regulation, and may be important in regulating the set point and regulating body weight towards the set point. Changing leptin levels – either associated with weight gain or loss, or induced via central or peripheral administration in animal models – directly alter feeding behaviour and energy expenditure. Individuals who, due to genetic mutation, are unable to produce functional leptin or who produce leptin but are insensitive to it are prone to develop obesity. [4] This has been confirmed by experimental "knockdown" of leptin receptors in the lateral hypothalamus in rats, which caused the rats to consume more calories and increase in body weight compared to control rats. [9] However, most human obesity is not linked to failure to normally process leptin. [4]

Criticism and alternatives

While set point theory has been supported in animals and humans, it may not apply to humans eating a western diet, which may be obesogenic to an extent that it overcomes the homeostatic process set forth in set point theory. [3] Set point theory does not on its own explain why body mass index for humans, measured as a proxy for fat, tends to change with increasing age or why obesity levels in a population vary depending on socioeconomic or environmental factors (or why weight tends to change for an individual when socioeconomic status and environment change). [4]

One alternative to set point theory is settling points. With settling points, an increase (or decrease) in calories consumed leads to an increase (or decrease) of energy expended until an equilibrium is reached; this differs from the set point theory in that the increase (or decrease) in energy expenditure may be driven by an increase (or decrease) in fat or lean mass without regard to a fixed set weigh or fat level and without active regulation to offset the increased (or decreased) consumption. [4] However, the return to normal weight after subjects have their caloric intake strictly limited happens faster than would be expected in a model without active regulation (i.e. subjects return to normal weight faster than if they simply returned to normal eating habits). [4]

Another alternative is the dual intervention point model. The dual intervention point model posits that rather than a body weight set point, there is a set range for body weight. Under this model, active compensation happens only outside of upper and lower intervention points, while for weights within the set range environmental factors would have a strong effect on body weight since there would only be passive compensation for changes in weight. [4] Differences in propensity for obesity between individuals would then be explained as individuals prone to obesity having a wide set range that extends into higher weights. [4] In the dual intervention model, the lower and upper limits of the range are independently set, with the lower end of the range set by evolutionary pressure due to the risk of starvation if too much weight is lost and the upper bound set by pressure due to increased risk of predation if too much weight is gained.

See also

Related Research Articles

<span class="mw-page-title-main">Leptin</span> Hormone that inhibits hunger

Leptin is a protein hormone predominantly made by adipocytes. Its primary role is likely to regulate long-term energy balance.

<span class="mw-page-title-main">Adipose tissue</span> Loose connective tissue composed mostly by adipocytes

Adipose tissue is a loose connective tissue composed mostly of adipocytes. It also contains the stromal vascular fraction (SVF) of cells including preadipocytes, fibroblasts, vascular endothelial cells and a variety of immune cells such as adipose tissue macrophages. Its main role is to store energy in the form of lipids, although it also cushions and insulates the body.

Basal metabolic rate (BMR) is the rate of energy expenditure per unit time by endothermic animals at rest. It is reported in energy units per unit time ranging from watt (joule/second) to ml O2/min or joule per hour per kg body mass J/(h·kg). Proper measurement requires a strict set of criteria to be met. These criteria include being in a physically and psychologically undisturbed state and being in a thermally neutral environment while in the post-absorptive state (i.e., not actively digesting food). In bradymetabolic animals, such as fish and reptiles, the equivalent term standard metabolic rate (SMR) applies. It follows the same criteria as BMR, but requires the documentation of the temperature at which the metabolic rate was measured. This makes BMR a variant of standard metabolic rate measurement that excludes the temperature data, a practice that has led to problems in defining "standard" rates of metabolism for many mammals.

<span class="mw-page-title-main">Adipocyte</span> Cells that primarily compose adipose tissue, specialized in storing energy as fat

Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Adipocytes are derived from mesenchymal stem cells which give rise to adipocytes through adipogenesis. In cell culture, adipocyte progenitors can also form osteoblasts, myocytes and other cell types.

<span class="mw-page-title-main">Neuropeptide Y</span> Mammalian protein found in Homo sapiens

Neuropeptide Y (NPY) is a 36 amino-acid neuropeptide that is involved in various physiological and homeostatic processes in both the central and peripheral nervous systems. It is secreted alongside other neurotransmitters such as GABA and glutamate. 

<span class="mw-page-title-main">Weight gain</span> Increase in a persons total body mass

Weight gain is an increase in body weight. This can involve an increase in muscle mass, fat deposits, excess fluids such as water or other factors. Weight gain can be a symptom of a serious medical condition.

Calorie restriction is a dietary regimen that reduces the energy intake from foods and beverages without incurring malnutrition. The possible effect of calorie restriction on body weight management, longevity, and aging-associated diseases has been an active area of research.

<span class="mw-page-title-main">Oleoyl-estrone</span> Chemical compound

Oleoyl-estrone (OE), or estrone 3-oleate, is a fatty acid ester of estrone. It is a naturally circulating hormone in animals, including humans. It was studied as a potential weight-loss drug, but failed to show benefit in clinical trials. It was first reported in 1996 to cause a body fat loss effect in rats in the International Journal of Obesity and Related Metabolic Disorders. The animal research has all been conducted by the Nitrogen-Obesity Research Group of the University of Barcelona.

<span class="mw-page-title-main">Jeffrey M. Friedman</span>

Jeffrey M. Friedman is a molecular geneticist at New York City's Rockefeller University and an Investigator of the Howard Hughes Medical Institute. His discovery of the hormone leptin and its role in regulating body weight has had a major role in the area of human obesity. Friedman is a physician scientist studying the genetic mechanisms that regulate body weight. His research on various aspects of obesity received national attention in late 1994, when it was announced that he and his colleagues had isolated the mouse ob gene and its human homologue. They subsequently found that injections of the encoded protein, leptin, decreases body weight of mice by reducing food intake and increasing energy expenditure. Current research is aimed at understanding the genetic basis of obesity in human and the mechanisms by which leptin transmits its weight-reducing signal.

Nesfatin-1 is a neuropeptide produced in the hypothalamus of mammals. It participates in the regulation of hunger and fat storage. Increased nesfatin-1 in the hypothalamus contributes to diminished hunger, a 'sense of fullness', and a potential loss of body fat and weight.

<span class="mw-page-title-main">FTO gene</span> Protein-coding gene in the species Homo sapiens

Fat mass and obesity-associated protein also known as alpha-ketoglutarate-dependent dioxygenase FTO is an enzyme that in humans is encoded by the FTO gene located on chromosome 16. As one homolog in the AlkB family proteins, it is the first mRNA demethylase that has been identified. Certain alleles of the FTO gene appear to be correlated with obesity in humans.

<span class="mw-page-title-main">Central melanocortin system</span> System involved in the regulation of weight and peripheral tissue such as hair and skin

The central melanocortin system is defined anatomically as a collection of central nervous system circuits which include:

In biology, energy homeostasis, or the homeostatic control of energy balance, is a biological process that involves the coordinated homeostatic regulation of food intake and energy expenditure. The human brain, particularly the hypothalamus, plays a central role in regulating energy homeostasis and generating the sense of hunger by integrating a number of biochemical signals that transmit information about energy balance. Fifty percent of the energy from glucose metabolism is immediately converted to heat.

Hunger is a sensation that motivates the consumption of food. The sensation of hunger typically manifests after only a few hours without eating and is generally considered to be unpleasant. Satiety occurs between 5 and 20 minutes after eating. There are several theories about how the feeling of hunger arises. The desire to eat food, or appetite, is another sensation experienced with regard to eating.

<span class="mw-page-title-main">Weight management</span> Techniques for maintaining body weight

Weight management refers to behaviors, techniques, and physiological processes that contribute to a person's ability to attain and maintain a healthy weight. Most weight management techniques encompass long-term lifestyle strategies that promote healthy eating and daily physical activity. Moreover, weight management involves developing meaningful ways to track weight over time and to identify the ideal body weights for different individuals.

Sleep is important in regulating metabolism. Mammalian sleep can be sub-divided into two distinct phases - REM and non-REM (NREM) sleep. In humans and cats, NREM sleep has four stages, where the third and fourth stages are considered slow-wave sleep (SWS). SWS is considered deep sleep, when metabolism is least active.

<span class="mw-page-title-main">E-6837</span> Chemical compound

E-6837 is an orally active, 5-HT6 agonist developed in an attempt to create an anti-obesity medication. In cell lines expressing rat 5-HT6 receptors, it acted as a partial agonist (on presumed silent receptors), while it acted as a full agonist on human 5-HT6 receptors (which are constitutively active). Oral administration of E-6837 reduced food intake, but only transiently. In rats, twice daily administration of E-6837 over the course of 4 weeks resulted in a 15.7% reduction in body weight, compared to 11% reduction for sibutramine. This weight loss remained significant for E-6837 after a 43-day withdrawal period, whereas the weight difference was non-significant for sibutramine (i.e., sibutramine had a rebound effect while E-6837 did not), and this weight loss was found to be due to a loss of fat mass. The reduction in fat mass in E-6837 treated animals was associated with a 50% decrease in plasma leptin levels, and also reduced glucose and insulin levels in plasma after a glucose tolerance test. This indicates that weight loss from E-6837 is associated with improved insulin sensitivity, and thus, better glycemic control.

Ingestive behaviors encompass all eating and drinking behaviors. These actions are influenced by physiological regulatory mechanisms; these mechanisms exist to control and establish homeostasis within the human body. Disruptions in these ingestive regulatory mechanisms can result in eating disorders such as obesity, anorexia, and bulimia.

Sleep and weight is the association between the amount of sleep an individual obtains and the weight of that individual.

Obesity is defined as an abnormal accumulation of body fat, usually 20% or more over an individual's ideal body weight. This is often described as a body mass index (BMI) over 30. However, BMI does not account for whether the excess weight is fat or muscle, and is not a measure of body composition. For most people, however, BMI is an indication used worldwide to estimate nutritional status. Obesity is usually the result of consuming more calories than the body needs and not expending that energy by doing exercise. There are genetic causes and hormonal disorders that cause people to gain significant amounts of weight but this is rare. People in the obese category are much more likely to suffer from fertility problems than people of normal healthy weight.

References

  1. 1 2 3 Harris, R. B. (December 1990). "Role of set-point theory in regulation of body weight". FASEB Journal. 4 (15): 3310–3318. doi: 10.1096/fasebj.4.15.2253845 . PMID   2253845. S2CID   21297643.
  2. 1 2 3 Keesey, Richard E.; Hirvonen, Matt D. (1 September 1997). "Body Weight Set-Points: Determination and Adjustment". The Journal of Nutrition. 127 (9): 1875S–1883S. doi: 10.1093/jn/127.9.1875S . PMID   9278574.
  3. 1 2 Ghanemi A, Yoshioka M, St-Amand J (2018). "Broken Energy Homeostasis and Obesity Pathogenesis: The Surrounding Concepts". J Clin Med. 7 (11): 453. doi: 10.3390/jcm7110453 . PMC   6262529 . PMID   30463389.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. 1 2 3 4 5 6 7 8 9 Speakman, John R.; Levitsky, David A.; Allison, David B.; Bray, Molly S.; Castro, John M. de; Clegg, Deborah J.; Clapham, John C.; Dulloo, Abdul G.; Gruer, Laurence; Haw, Sally; Hebebrand, Johannes; Hetherington, Marion M.; Higgs, Susanne; Jebb, Susan A.; Loos, Ruth J. F.; Luckman, Simon; Luke, Amy; Mohammed-Ali, Vidya; O’Rahilly, Stephen; Pereira, Mark; Perusse, Louis; Robinson, Tom N.; Rolls, Barbara; Symonds, Michael E.; Westerterp-Plantenga, Margriet S. (1 November 2011). "Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity". Disease Models & Mechanisms. 4 (6): 733–745. doi: 10.1242/dmm.008698 . PMC   3209643 . PMID   22065844.
  5. ↑ Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM; et al. (2017). "Obesity Pathogenesis: An Endocrine Society Scientific Statement". Endocr Rev. 38 (4): 267–296. doi:10.1210/er.2017-00111. PMC   5546881 . PMID   28898979.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ↑ Müller, Manfred J; Bosy-Westphal, Anja; Heymsfield, Steven B (2010-08-09). "Is there evidence for a set point that regulates human body weight?". F1000 Medicine Reports. 2: 59. doi: 10.3410/M2-59 . ISSN   1757-5931. PMC   2990627 . PMID   21173874.
  7. ↑ Keys, A.; Brožek, J.; Henschel, A.; Mickelsen, O.; Taylor, H. L. (1950). The Biology of Human Starvation (2 volumes). St. Paul, MN: University of Minnesota Press, MINNE edition. ISBN   978-0-8166-7234-9.[ page needed ]
  8. ↑ Bernardis, Lee L.; McEwent, Geraldine; Kodis, Marjorie (1 September 1986). "Body weight set point studies in weanling rats with dorsomedial hypothalamic lesions (DMNL rats)". Brain Research Bulletin. 17 (3): 451–460. doi:10.1016/0361-9230(86)90254-6. PMID   3533223. S2CID   4765497.
  9. ↑ Davis, Jon F.; Choi, Derrick L.; Schurdak, Jennifer D.; Fitzgerald, Maureen F.; Clegg, Deborah J.; Lipton, Jack W.; Figlewicz, Dianne P.; Benoit, Stephen C. (1 April 2011). "Leptin Regulates Energy Balance and Motivation Through Action at Distinct Neural Circuits". Biological Psychiatry. 69 (7): 668–674. doi:10.1016/j.biopsych.2010.08.028. PMC   3058141 . PMID   21035790.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.